Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

  1. Fernández, O.
  2. Izquierdo, G.
  3. Fernández, V.
  4. Leyva, L.
  5. Reyes, V.
  6. Guerrero, M.
  7. León, A.
  8. Arnaiz, C.
  9. Navarro, G.
  10. Páramo, M.D.
  11. De la Cuesta, A.
  12. Soria, B.
  13. Hmadcha, A.
  14. Pozo, D.
  15. Fernandez-Montesinos, R.
  16. Leal, M.
  17. Ochotorena, I.
  18. Gálvez, P.
  19. Geniz, M.A.
  20. Barón, F.J.
  21. Mata, R.
  22. Medina, C.
  23. Caparrós-Escudero, C.
  24. Cardesa, A.
  25. Cuende, N.
Journal:
PLoS ONE

ISSN: 1932-6203

Year of publication: 2018

Volume: 13

Issue: 5

Type: Article

DOI: 10.1371/JOURNAL.PONE.0195891 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus